Vaxcyte Inc (PCVX) returns
$62.03 -0.93% Close Oct 30, 2026 Live
Vaxcyte returns over 5 years
$1,000 invested in Vaxcyte five years ago was worth $2,651 at the close on October 30, 2026, with dividends reinvested: an average return of 21.5% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
PCVX, $10,000 investedS&P 500 (SPY)
$10,000$20,000$30,000
202120222023202420252026
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +9.0% | — | $1,090 | -0.9% |
| 3 months | +10.8% | — | $1,108 | +2.1% |
| Year to date | +34.4% | — | $1,344 | +11.7% |
| 1 year | +38.6% | — | $1,386 | +12.4% |
| 3 years | +30.3% | +9.2% | $1,303 | +88.5% |
| 5 years | +165.1% | +21.5% | $2,651 | +76.0% |
Vaxcyte return by calendar year
| Year | PCVX | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +34.4% | +11.7% | +22.7% |
| 2025 | -43.6% | +17.7% | -61.4% |
| 2024 | +30.4% | +24.9% | +5.5% |
| 2023 | +31.0% | +26.2% | +4.8% |
| 2022 | +101.6% | -18.2% | +119.7% |
| 2021 | -10.5% | +28.7% | -39.2% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Vaxcyte Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.